Recent News
More Manufacturers Pull Generic Zantac Over Carcinogen Concerns
Manufacturers such as GlaxoSmithKline are pulling generic forms of Zantac off of the market, after Novartis’ Sandoz Inc. issued a voluntary recall earlier this week due to confirmed carcinogen contamination. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss the updates to the ongoing Zantac claims. GlaxoSmithKline has stopped global distribution…
Zantac Manufacturer Recalls Medication Due to Confirmed Contamination
Sandoz Inc. has voluntarily recalled the generic version of common medication Zantac after the medication was confirmed to be contaminated with a human carcinogen. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss the updates to the ongoing Zantac claims. Global health regulators recently raised concerns about the possibility that the…
Carcinogen Found in Stomach Drug Leads to Halt in Distribution
Global health regulators have raised the alarm about the possibility that the widely used drug, Zantac, could be tainted with the same cancer-causing agent found in Valsartan earlier this year. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos detail the preliminary results of the FDA and EU probes. Officials are Investigating…